Lumibird SA (LBIRD) - Total Assets
Based on the latest financial reports, Lumibird SA (LBIRD) holds total assets worth €428.90 Million EUR (≈ $501.43 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore LBIRD operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Lumibird SA - Total Assets Trend (2000–2025)
This chart illustrates how Lumibird SA's total assets have evolved over time, based on quarterly financial data. See what is Lumibird SA's book value for net asset value and shareholders' equity analysis.
Lumibird SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Lumibird SA's total assets of €428.90 Million consist of 50.6% current assets and 49.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.4% |
| Accounts Receivable | €63.34 Million | 14.8% |
| Inventory | €82.47 Million | 19.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €67.33 Million | 15.7% |
| Goodwill | €70.80 Million | 16.5% |
Asset Composition Trend (2000–2025)
This chart illustrates how Lumibird SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Lumibird SA market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lumibird SA's current assets represent 50.6% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, up from 1.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, a decrease from 44.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 19.2% of total assets.
Lumibird SA Competitors by Total Assets
Key competitors of Lumibird SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
China | CN¥2.35 Billion |
|
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439
|
China | CN¥3.66 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
INIFY LABORATORIES AB
F:WY60
|
Germany | €204.64 Million |
|
Check Cap Ltd
NASDAQ:CHEK
|
USA | $377.00K |
Lumibird SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.47 | 2.63 | 2.83 |
| Quick Ratio | 1.53 | 1.66 | 2.17 |
| Cash Ratio | 0.00 | 0.69 | 0.00 |
| Working Capital | €129.20 Million | €129.21 Million | €104.94 Million |
Lumibird SA - Advanced Valuation Insights
This section examines the relationship between Lumibird SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.32 |
| Latest Market Cap to Assets Ratio | 1.14 |
| Asset Growth Rate (YoY) | -0.2% |
| Total Assets | €428.90 Million |
| Market Capitalization | $489.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values Lumibird SA's assets above their book value (1.14x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Lumibird SA's assets decreased by 0.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Lumibird SA (2000–2025)
The table below shows the annual total assets of Lumibird SA from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €428.90 Million ≈ $501.43 Million |
-0.21% |
| 2024-12-31 | €429.80 Million ≈ $502.48 Million |
+6.06% |
| 2023-12-31 | €405.25 Million ≈ $473.78 Million |
+8.92% |
| 2022-12-31 | €372.04 Million ≈ $434.96 Million |
+7.03% |
| 2021-12-31 | €347.62 Million ≈ $406.41 Million |
+13.81% |
| 2020-12-31 | €305.43 Million ≈ $357.08 Million |
+57.64% |
| 2019-12-31 | €193.76 Million ≈ $226.52 Million |
+28.29% |
| 2018-12-31 | €151.03 Million ≈ $176.58 Million |
+24.74% |
| 2017-12-31 | €121.08 Million ≈ $141.55 Million |
+97.87% |
| 2016-12-31 | €61.19 Million ≈ $71.54 Million |
+0.13% |
| 2015-12-31 | €61.11 Million ≈ $71.44 Million |
+10.99% |
| 2014-12-31 | €55.06 Million ≈ $64.37 Million |
+6.92% |
| 2013-12-31 | €51.49 Million ≈ $60.20 Million |
-2.31% |
| 2012-12-31 | €52.71 Million ≈ $61.62 Million |
-9.57% |
| 2011-12-31 | €58.29 Million ≈ $68.15 Million |
+5.44% |
| 2010-12-31 | €55.28 Million ≈ $64.63 Million |
+0.94% |
| 2009-12-31 | €54.77 Million ≈ $64.03 Million |
-20.97% |
| 2008-12-31 | €69.30 Million ≈ $81.02 Million |
-0.15% |
| 2007-12-31 | €69.41 Million ≈ $81.14 Million |
+25.69% |
| 2006-12-31 | €55.22 Million ≈ $64.56 Million |
+25.76% |
| 2005-12-31 | €43.91 Million ≈ $51.34 Million |
+61.43% |
| 2004-12-31 | €27.20 Million ≈ $31.80 Million |
-3.42% |
| 2003-12-31 | €28.16 Million ≈ $32.92 Million |
-11.89% |
| 2002-12-31 | €31.96 Million ≈ $37.37 Million |
-3.89% |
| 2001-12-31 | €33.26 Million ≈ $38.88 Million |
-81.07% |
| 2000-12-31 | €175.71 Million ≈ $205.42 Million |
-- |
About Lumibird SA
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. It offers fiber lasers and amplifiers, high power fiber lasers, and solid-state lasers, laser diodes and components; and doppler wind LiDAR, … Read more